# Kyrgyzstan Chemicals Export Opportunities (HS 28-38)

![Yugalinks](https://www.yugalinks.com/trade/yugalinks-logo-v3-dark-mode.webp)

> Yugalinks sector export playbook

Explore Kyrgyzstan HS 28-38 chemicals export opportunities, product portfolio, buyer markets, growth signals, and diversification opportunities.

## Overview

- Exporter: Kyrgyzstan (KGZ)
- Sector: Chemicals
- HS chapters: HS 28-38
- Latest trade year: 2024
- Sector exports: $6.4M
- Products: 14
- Buyer markets: 24
- Average CAGR: +2.2%
- Global sector size: $308.3B

## Product portfolio

| Product | Global size | Your exports | Opportunity | CAGR | Markets | Share |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| HS 300490 - Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale | $223.1B | $300.3K | $91.3B | +3.2% | 16 | +0.0% |
| HS 330499 - Cosmetic and toilet preparations: n.e.c. in heading no. 3304, for the care of the skin (excluding medicaments, including sunscreen or sun tan preparations) | $22.3B | $31.8K | $9.3B | +25.3% | 7 | +0.0% |
| HS 330300 - Perfumes and toilet waters | $8.8B | $11.0K | $4.9B | -0.2% | 4 | +0.0% |
| HS 284410 - Uranium: natural uranium and its compounds, alloys, dispersions (including cermets), ceramic products and mixtures containing natural uranium or natural uranium compounds | $4.5B | $5.6M | $4.8B | -15.3% | 3 | +0.4% |
| HS 382200 - Reagents: diagnostic or laboratory reagents on a backing and prepared diagnostic or laboratory reagents whether or not on a backing, other than those of heading no. 3002 or 3006: certified reference material | $12.4B | $36.7K | $4.6B | +29.4% | 3 | +0.0% |
| HS 381800 - Chemical elements: doped for use in electronics, in the form of discs, wafers or similar forms: chemical compounds doped for use in electronics | $7.9B | $359.9 | $4.1B | -58.3% | 3 | +0.0% |
| HS 382499 - Chemical products, mixtures and preparations: n.e.c. heading 3824 | $5.8B | $13.5K | $3.7B | -14.6% | 4 | +0.0% |
| HS 300212 - Blood, human or animal, antisera, other blood fractions and immunological products: antisera and other blood fractions | $7.5B | $21.8 | $3.5B | +26.5% | 1 | +0.0% |
| HS 293499 - Nucleic acids and their salts, other heterocyclic compounds, n.e.c. in heading number 2934 | $6.2B | $353.6K | $2.8B | +237.2% | 1 | +0.0% |
| HS 300290 - Toxins, cultures of micro-organisms (excluding yeasts) and similar products | $4.9B | $15.9 | $2.5B | -26.8% | 3 | +0.0% |
| HS 284690 - Compounds, inorganic or organic (excluding cerium), of rare-earth metals, of yttrium, scandium or of mixtures of these metals | $1.4B | $9.4K | $1.5B | -10.2% | 1 | +0.0% |
| HS 280461 - Silicon: containing by weight not less than 99.99% of silicon | $1.4B | $69.2K | $1.4B | +6.7% | 2 | +0.0% |
| HS 330210 - Odoriferous substances and mixtures: of a kind used in the food or drink industries | $1.0B | $0.1 | $647.5M | -87.3% | 1 | +0.0% |
| HS 340600 - Candles, tapers and the like | $1.0B | $65.4 | $640.9M | -26.6% | 1 | +0.0% |

## Best markets

- USA, Puerto Rico and US Virgin Islands (USA): $31.0B calculated opportunity across 8 products.
- Switzerland, Liechtenstein (CHE): $27.7B calculated opportunity across 1 products.
- China (CHN): $12.4B calculated opportunity across 6 products.
- Slovenia (SVN): $9.7B calculated opportunity across 1 products.
- Germany (DEU): $8.8B calculated opportunity across 6 products.
- Belgium (BEL): $7.0B calculated opportunity across 1 products.
- Russia (RUS): $5.8B calculated opportunity across 3 products.
- Netherlands (NLD): $5.3B calculated opportunity across 1 products.
- France (FRA): $4.7B calculated opportunity across 3 products.
- Canada (CAN): $3.9B calculated opportunity across 1 products.
- Ireland (IRL): $3.2B calculated opportunity across 1 products.
- Taiwan (TWN): $3.1B calculated opportunity across 2 products.

## Growth stars

- HS 293499: +237.2% average CAGR, $2.8B calculated opportunity.
- HS 382200: +29.4% average CAGR, $4.6B calculated opportunity.
- HS 300212: +26.5% average CAGR, $3.5B calculated opportunity.
- HS 330499: +25.3% average CAGR, $9.3B calculated opportunity.
- HS 280461: +6.7% average CAGR, $1.4B calculated opportunity.
- HS 300490: +3.2% average CAGR, $91.3B calculated opportunity.
- HS 330300: -0.2% average CAGR, $4.9B calculated opportunity.
- HS 284690: -10.2% average CAGR, $1.5B calculated opportunity.
- HS 382499: -14.6% average CAGR, $3.7B calculated opportunity.
- HS 284410: -15.3% average CAGR, $4.8B calculated opportunity.

## Diversification opportunities

- HS 300490: 16 buyer markets, $91.3B calculated opportunity.
- HS 330499: 7 buyer markets, $9.3B calculated opportunity.
- HS 330300: 4 buyer markets, $4.9B calculated opportunity.
- HS 382499: 4 buyer markets, $3.7B calculated opportunity.
- HS 284410: 3 buyer markets, $4.8B calculated opportunity.
- HS 382200: 3 buyer markets, $4.6B calculated opportunity.
- HS 381800: 3 buyer markets, $4.1B calculated opportunity.
- HS 300290: 3 buyer markets, $2.5B calculated opportunity.
- HS 280461: 2 buyer markets, $1.4B calculated opportunity.
- HS 300212: 1 buyer markets, $3.5B calculated opportunity.

## Method

Reported trade observations and calculated indicators are shown separately. Validate buyers, standards, logistics, pricing, and competition before acting. [Read the Yugalinks methodology](https://www.yugalinks.com/methodology).

## Data sources

- Primary trade series: OECD (2025), Balanced international merchandise trade statistics (BIMTS) - HS2017-6D, OECD Data Explorer (accessed on 2026-08-30). [OECD Data Explorer](https://data-explorer.oecd.org/) - [OECD Terms & Conditions](https://www.oecd.org/termsandconditions/)
- CEPII BACI bilateral trade flows (202601): [dataset page](https://www.cepii.fr/CEPII/en/bdd_modele/bdd_modele_item.asp?id=37) - [BACI documentation](https://www.cepii.fr/DATA_DOWNLOAD/baci/doc/baci_webpage.html) - [Etalab 2.0 Open Licence](https://www.etalab.gouv.fr/wp-content/uploads/2018/11/open-licence.pdf)

This page presents derived Yugalinks views of reported observations and calculated indicators.